UA110170C2 - BCL-2 SELECTIVE AGENTS WHICH CAUSE APOPTOSIS FOR TREATMENT OF CANCER AND IMMUNE DISEASES - Google Patents

BCL-2 SELECTIVE AGENTS WHICH CAUSE APOPTOSIS FOR TREATMENT OF CANCER AND IMMUNE DISEASES

Info

Publication number
UA110170C2
UA110170C2 UAA201409941A UAA201409941A UA110170C2 UA 110170 C2 UA110170 C2 UA 110170C2 UA A201409941 A UAA201409941 A UA A201409941A UA A201409941 A UAA201409941 A UA A201409941A UA 110170 C2 UA110170 C2 UA 110170C2
Authority
UA
Ukraine
Prior art keywords
bcl
cancer
treatment
immune diseases
selective agents
Prior art date
Application number
UAA201409941A
Other languages
Russian (ru)
Ukrainian (uk)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of UA110170C2 publication Critical patent/UA110170C2/en

Links

Abstract

Описані сполуки, які інгібують активність антиапоптотичних білків Bcl-2 і Bcl-xL, композиції, що містять дані сполуки, і способи лікування захворювань, у ході яких експресується антиапоптичний білок Bcl-2.Compounds that inhibit the activity of the anti-apoptotic proteins Bcl-2 and Bcl-xL, compositions containing these compounds, and methods for treating diseases in which the anti-apoptotic protein Bcl-2 is expressed are described.

UAA201409941A 2008-12-05 2009-12-04 BCL-2 SELECTIVE AGENTS WHICH CAUSE APOPTOSIS FOR TREATMENT OF CANCER AND IMMUNE DISEASES UA110170C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12027508P 2008-12-05 2008-12-05

Publications (1)

Publication Number Publication Date
UA110170C2 true UA110170C2 (en) 2015-11-25

Family

ID=52989304

Family Applications (2)

Application Number Title Priority Date Filing Date
UAA201108414A UA107655C2 (en) 2008-12-05 2009-04-12 SELECTIVE BCL-2 ANTIAPOPTIC PROTEIN INHIBITORS FOR TREATMENT OF CANCER AND IMMUNE DISEASES
UAA201409941A UA110170C2 (en) 2008-12-05 2009-12-04 BCL-2 SELECTIVE AGENTS WHICH CAUSE APOPTOSIS FOR TREATMENT OF CANCER AND IMMUNE DISEASES

Family Applications Before (1)

Application Number Title Priority Date Filing Date
UAA201108414A UA107655C2 (en) 2008-12-05 2009-04-12 SELECTIVE BCL-2 ANTIAPOPTIC PROTEIN INHIBITORS FOR TREATMENT OF CANCER AND IMMUNE DISEASES

Country Status (1)

Country Link
UA (2) UA107655C2 (en)

Also Published As

Publication number Publication date
UA107655C2 (en) 2015-02-10

Similar Documents

Publication Publication Date Title
UA108193C2 (en) APOPTOZINDUCE FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTO-IMMUNE DISEASES
PH12018501264A1 (en) Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
UA107706C2 (en) Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
PH12015500297A1 (en) Adoptosis-inducing agents for the treatment of cancer and immune and automoimmune disease
MY158932A (en) Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
UA106403C2 (en) Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
UA106640C2 (en) Bcl-2-Selective Apoptosis Inducer for Cancer and Immune Diseases
NZ631701A (en) Apoptosis-including agents for the treatment of cancer and immune and autoimmune diseases
MX2011007681A (en) Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases.
SG10201406608YA (en) Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
UA112326C2 (en) APOPTOSIS CAUSES FOR TREATMENT OF Malignant Neoplasms And Immune And Autoimmune Diseases
UA110170C2 (en) BCL-2 SELECTIVE AGENTS WHICH CAUSE APOPTOSIS FOR TREATMENT OF CANCER AND IMMUNE DISEASES